Skip to main content
ASTH
NASDAQ Trade & Services

Astrana Health Reports Strong Q1 2026 Results with 56% Revenue Growth and Reaffirms Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$35
Mkt Cap
$1.789B
52W Low
$18.08
52W High
$36.2
52W Position info
94% above low
Off High info
3.3% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ASTH sits 94% above its 52-week low of $18.08.

Summary

Astrana Health reported strong Q1 2026 financial results, with revenue up 56% and adjusted EBITDA up 82% year-over-year, while reaffirming its full-year 2026 guidance.


Key Events · Earnings and Guidance · ASTH

  • Strong First Quarter 2026 Financial Results

    Astrana Health reported total revenue of $965.1 million, up 56% year-over-year, and adjusted EBITDA of $66.3 million, an 82% increase. Net income attributable to Astrana rose 116% to $14.4 million, with diluted EPS at $0.29, up 107%.

  • Reaffirmed Full-Year 2026 Guidance

    The company reiterated its full-year 2026 guidance, expecting total revenue between $3.8 billion and $4.1 billion, and adjusted EBITDA between $250 million and $280 million. New Q2 2026 guidance projects revenue of $965 million to $1.0 billion and adjusted EBITDA of $65 million to $70 million.

  • Operational Progress in Full-Risk Contracts and Deleveraging

    Astrana Health achieved 80% of its Q1 2026 Care Partners capitation revenue from full-risk arrangements and expanded Medicare Advantage membership in Texas to over 14,000. Net leverage declined to approximately 2.3x on a pro forma trailing twelve-month basis.


Analysis · ASTH · Trade & Services

Astrana Health delivered robust financial performance in the first quarter of 2026, with total revenue surging 56% year-over-year to $965.1 million and adjusted EBITDA increasing 82% to $66.3 million. Net income attributable to Astrana more than doubled, rising 116% to $14.4 million, and diluted EPS grew 107% to $0.29. These strong results are complemented by significant operational progress, including 80% of Q1 Care Partners capitation revenue now derived from full-risk arrangements and continued deleveraging, with net leverage declining to approximately 2.3x. The company also reiterated its full-year 2026 guidance for total revenue ($3.8B - $4.1B) and adjusted EBITDA ($250M - $280M), providing stability and confidence, particularly in light of the previously disclosed material weakness in internal controls. This positive earnings report, coupled with strategic operational advancements, suggests a strong trajectory for the company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ASTH was trading at $35.00 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $18.08 to $36.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ASTH - Latest Insights

ASTH
Nov 06, 2026, 6:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $39.01
Real-time Price: $28.90 info
Change: -$10.11 (-26%) info
Market Cap: $1.434B info
ASTH
Nov 05, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $39.01
Real-time Price: $28.90 info
Change: -$10.11 (-26%) info
Market Cap: $1.434B info
ASTH
Sep 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.11
Real-time Price: $28.90 info
Change: -$6.21 (-18%) info
Market Cap: $1.434B info
ASTH
Aug 10, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $37.47
Real-time Price: $28.90 info
Change: -$8.57 (-23%) info
Market Cap: $1.434B info
ASTH
Aug 06, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.70
Real-time Price: $28.90 info
Change: -$4.80 (-14%) info
Market Cap: $1.434B info